Hakim Bouamar

1.1k total citations
31 papers, 779 citations indexed

About

Hakim Bouamar is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Hakim Bouamar has authored 31 papers receiving a total of 779 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 13 papers in Cancer Research and 11 papers in Oncology. Recurrent topics in Hakim Bouamar's work include MicroRNA in disease regulation (5 papers), Ferroptosis and cancer prognosis (4 papers) and Cancer Cells and Metastasis (4 papers). Hakim Bouamar is often cited by papers focused on MicroRNA in disease regulation (5 papers), Ferroptosis and cancer prognosis (4 papers) and Cancer Cells and Metastasis (4 papers). Hakim Bouamar collaborates with scholars based in United States, China and France. Hakim Bouamar's co-authors include Daifeng Jiang, An-Ping Lin, Ricardo C.T. Aguiar, Kumaraguruparan Ramasamy, Sang Woo Kim, Lu‐Zhe Sun, Chun-Lin Lin, Manoela Marques Ortega, Fawzia Louache and Tim H‐M Huang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and PLoS ONE.

In The Last Decade

Hakim Bouamar

31 papers receiving 773 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hakim Bouamar United States 14 427 325 200 195 125 31 779
Francesco Boccalatte United States 12 536 1.3× 188 0.6× 156 0.8× 193 1.0× 102 0.8× 21 804
Ester Alvino Italy 17 500 1.2× 280 0.9× 106 0.5× 189 1.0× 98 0.8× 35 813
Andrea Pelosi Italy 18 489 1.1× 300 0.9× 297 1.5× 202 1.0× 52 0.4× 35 912
Hao Lu China 15 355 0.8× 275 0.8× 243 1.2× 120 0.6× 44 0.4× 43 722
François Kuonen Switzerland 17 298 0.7× 148 0.5× 171 0.9× 287 1.5× 45 0.4× 42 712
Yixiao Gong United States 10 574 1.3× 157 0.5× 162 0.8× 189 1.0× 45 0.4× 14 915
Lirong Pei United States 12 559 1.3× 211 0.6× 104 0.5× 174 0.9× 61 0.5× 20 790
Katoh Japan 12 579 1.4× 179 0.6× 112 0.6× 229 1.2× 55 0.4× 17 841
Jeannine Diesch Australia 15 591 1.4× 152 0.5× 152 0.8× 155 0.8× 35 0.3× 20 852

Countries citing papers authored by Hakim Bouamar

Since Specialization
Citations

This map shows the geographic impact of Hakim Bouamar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hakim Bouamar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hakim Bouamar more than expected).

Fields of papers citing papers by Hakim Bouamar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hakim Bouamar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hakim Bouamar. The network helps show where Hakim Bouamar may publish in the future.

Co-authorship network of co-authors of Hakim Bouamar

This figure shows the co-authorship network connecting the top 25 collaborators of Hakim Bouamar. A scholar is included among the top collaborators of Hakim Bouamar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hakim Bouamar. Hakim Bouamar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zheng, Guixi, Lian‐Qiu Wu, Hakim Bouamar, et al.. (2024). Ficolin-3 induces apoptosis and suppresses malignant property of hepatocellular carcinoma cells via the complement pathway. Life Sciences. 357. 123103–123103. 2 indexed citations
2.
Bouamar, Hakim, Guixi Zheng, Junhua Yang, et al.. (2024). STEAP2 promotes hepatocellular carcinoma progression via increased copper levels and stress-activated MAP kinase activity. Scientific Reports. 14(1). 12753–12753. 4 indexed citations
3.
Das, Debodipta, Xiaojing Wang, Yu‐Chiao Chiu, et al.. (2024). Integrative multi-omics characterization of hepatocellular carcinoma in Hispanic patients. JNCI Journal of the National Cancer Institute. 116(12). 1961–1978. 2 indexed citations
4.
Das, Debodipta, Xiaojing Wang, Yu‐Chiao Chiu, et al.. (2023). Abstract 3175: Comprehensive multi-omic characterization of hepatocellular carcinoma in Hispanic patients. Cancer Research. 83(7_Supplement). 3175–3175. 1 indexed citations
5.
Bouamar, Hakim, Kate Lathrop, Ismail Jatoi, et al.. (2023). mTOR inhibition abrogates human mammary stem cells and early breast cancer progression markers. Breast Cancer Research. 25(1). 131–131. 5 indexed citations
6.
Lin, Min, Jianan Zhang, Hakim Bouamar, et al.. (2022). Fbxo22 promotes cervical cancer progression via targeting p57Kip2 for ubiquitination and degradation. Cell Death and Disease. 13(9). 805–805. 17 indexed citations
7.
Ortega, Manoela Marques & Hakim Bouamar. (2022). Guidelines on Designing MicroRNA Sponges: From Construction to Stable Cell Line. Methods in molecular biology. 2595. 171–183. 1 indexed citations
8.
Bouamar, Hakim, et al.. (2022). Abstract 1046: Combination of CDK 4/6 inhibitor Palbociclib with Rapamycin synergistically inhibits the growth of hepatocellular carcinoma cells. Cancer Research. 82(12_Supplement). 1046–1046. 1 indexed citations
9.
Chen, Guang, Hakim Bouamar, Bingzhi Wang, et al.. (2019). Everolimus Inhibits the Progression of Ductal Carcinoma In Situ to Invasive Breast Cancer Via Downregulation of MMP9 Expression. Clinical Cancer Research. 26(6). 1486–1496. 19 indexed citations
10.
Wang, Li‐Ju, Yu‐Chiao Chiu, Zhao Lai, et al.. (2019). An ancestry informative marker panel design for individual ancestry estimation of Hispanic population using whole exome sequencing data. BMC Genomics. 20(S12). 1007–1007. 11 indexed citations
11.
Chen, Guang, et al.. (2019). Everolimus induces G1 cell cycle arrest through autophagy-mediated protein degradation of cyclin D1 in breast cancer cells. American Journal of Physiology-Cell Physiology. 317(2). C244–C252. 25 indexed citations
12.
Zhu, Haiyan, Xiang Gu, Lu Xia, et al.. (2018). A Novel TGFβ Trap Blocks Chemotherapeutics-Induced TGFβ1 Signaling and Enhances Their Anticancer Activity in Gynecologic Cancers. Clinical Cancer Research. 24(12). 2780–2793. 54 indexed citations
13.
Zhu, Haiyan, Lu Xia, Qi Shen, et al.. (2018). Differential effects of GLI2 and GLI3 in regulating cervical cancer malignancy in vitro and in vivo. Laboratory Investigation. 98(11). 1384–1396. 12 indexed citations
14.
Ortega, Manoela Marques & Hakim Bouamar. (2016). Guidelines on Designing MicroRNA Sponges: From Construction to Stable Cell Line. Methods in molecular biology. 1509. 221–233. 5 indexed citations
15.
Huang, Guangcun, Paweł A. Osmulski, Hakim Bouamar, et al.. (2016). TGF-β signal rewiring sustains epithelial-mesenchymal transition of circulating tumor cells in prostate cancer xenograft hosts. Oncotarget. 7(47). 77124–77137. 15 indexed citations
16.
Lin, Chun-Lin, et al.. (2014). MicroRNA-21 inhibits p57Kip2 expression in prostate cancer. Molecular Cancer. 13(1). 212–212. 49 indexed citations
17.
Bouamar, Hakim, Saman Abbas, An-Ping Lin, et al.. (2013). A capture-sequencing strategy identifies IRF8, EBF1, and APRIL as novel IGH fusion partners in B-cell lymphoma. Blood. 122(5). 726–733. 40 indexed citations
18.
Coppo, Paul, Valérie Gouilleux‐Gruart, Yen‐Lin Huang, et al.. (2009). STAT3 transcription factor is constitutively activated and is oncogenic in nasal-type NK/T-cell lymphoma. Leukemia. 23(9). 1667–1678. 87 indexed citations
19.
Rivera, Sofía, Paule Opolon, Denis Biard, et al.. (2009). Novel Anti-Metastatic Action of Cidofovir Mediated by Inhibition of E6/E7, CXCR4 and Rho/ROCK Signaling in HPV+ Tumor Cells. PLoS ONE. 4(3). e5018–e5018. 42 indexed citations
20.
Zhang, Yanyan, et al.. (2009). Stromal Microenvironment Regulates Progenitor Survival through Nitric Oxide Production.. Blood. 114(22). 1440–1440. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Francesco Boccalatte Breakdown of academic impact, for papers by Ester Alvino Breakdown of academic impact, for papers by Andrea Pelosi Breakdown of academic impact, for papers by Hao Lu Breakdown of academic impact, for papers by François Kuonen Breakdown of academic impact, for papers by Yixiao Gong Breakdown of academic impact, for papers by Lirong Pei Breakdown of academic impact, for papers by Katoh Breakdown of academic impact, for papers by Jeannine Diesch
Rankless by CCL
2026